Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study

被引:0
|
作者
Weihong Zeng [1 ]
Tiansheng Wang [2 ]
Til Stürmer [2 ]
Na He [3 ]
Peng Shen [4 ]
Hongbo Lin [4 ]
Xiaodong Guan [1 ]
Yang Xu [1 ]
机构
[1] Peking University,Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center
[2] University of North Carolina at Chapel Hill,Department of Epidemiology, Gillings School of Global Public Health
[3] Peking University Third Hospital,Department of Pharmacy
[4] Yinzhou District Center for Disease Control and Prevention,Department of Chronic Disease and Health Promotion
关键词
Type 2 diabetes mellitus; Older; Angiotensin-converting enzyme inhibitors; Angiotensin II receptor blockers; Major cardiovascular events.;
D O I
10.1186/s12933-025-02753-1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes
    Bozkurt, Ozlem
    de Boer, Anthonius
    Grobbee, Diederik E.
    Kroon, Abraham A.
    Schiffers, Paul
    de Leeuw, Peter
    Klungel, Olaf H.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2009, 10 (02) : 101 - 108
  • [22] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [23] Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients
    Kido, Ryo
    Akizawa, Tadao
    Fukagawa, Masafumi
    Onishi, Yoshihiro
    Yamaguchi, Takuhiro
    Fukuhara, Shunichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2017, 46 (06) : 439 - 447
  • [24] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
  • [25] Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
    Ruilope, LM
    ACTA DIABETOLOGICA, 2005, 42 (Suppl 1) : S33 - S41
  • [26] Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults
    Dorosch, T.
    Ganzer, C. A.
    Lin, M.
    Seifan, A.
    CURRENT PAIN AND HEADACHE REPORTS, 2019, 23 (11)
  • [27] Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults
    T. Dorosch
    C. A. Ganzer
    M. Lin
    A. Seifan
    Current Pain and Headache Reports, 2019, 23
  • [28] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials
    Tocci, Giuliano
    Paneni, Francesco
    Palano, Francesca
    Sciarretta, Sebastiano
    Ferrucci, Andrea
    Kurtz, Theodore
    Mancia, Giuseppe
    Volpe, Massimo
    AMERICAN JOURNAL OF HYPERTENSION, 2011, 24 (05) : 582 - 590
  • [29] Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers: New-onset diabetes mellitus stratified by statin use
    Shin, Juyoung
    Kim, Hyunah
    Yim, Hyeon Woo
    Kim, Ju Han
    Lee, Suehyun
    Kim, Hun-Sung
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (01) : 97 - 103
  • [30] Comparison of Outcomes Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients With Myocardial Infarction: A Meta-Analysis
    Escobar, Johao
    Rawat, Anurag
    Maradiaga, Fabricio
    Isaak, Abraham K.
    Zainab, Sana
    Dari, Mohammedsefa Arusi
    Gdey, Martha Mekonen
    Khan, Areeba
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)